{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:52:12Z","timestamp":1791453132752,"version":"4.3.3"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtha.2024.02.013","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T06:43:05Z","timestamp":1709188985000},"page":"1541-1549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0255-4088","authenticated-orcid":false,"given":"Toshiaki","family":"Iba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-2674","authenticated-orcid":false,"given":"Cheryl L.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-582X","authenticated-orcid":false,"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-5299","authenticated-orcid":false,"given":"Marcel","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.02.013_bib1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib2","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2024.02.013_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jtha.2023.07.020","article-title":"Thromboinflammation in acute injury: infections, heatstroke, and trauma","volume":"22","author":"Iba","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib4","first-page":"191","article-title":"Proposal of the definition for COVID-19-associated coagulopathy","volume":"10","author":"Iba","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib5","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/S2213-2600(20)30216-2","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","volume":"8","author":"Jose","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib6","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib7","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.02.013_bib8","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/CM9.0000000000001019","article-title":"Focus on coronavirus disease 2019 associated coagulopathy","volume":"133","author":"Yang","year":"2020","journal-title":"Chin Med J"},{"key":"10.1016\/j.jtha.2024.02.013_bib9","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.pathol.2020.08.010","article-title":"Variability in D-dimer reporting revisited","volume":"53","author":"Favaloro","year":"2021","journal-title":"Pathology"},{"key":"10.1016\/j.jtha.2024.02.013_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023186","article-title":"Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019","volume":"99","author":"Creel-Bulos","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.jtha.2024.02.013_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017046","article-title":"New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey","volume":"7","author":"Iba","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jtha.2024.02.013_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40001-022-00655-6","article-title":"Major coagulation disorders and parameters in COVID-19 patients","volume":"27","author":"Teimury","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jtha.2024.02.013_bib13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.advms.2021.07.009","article-title":"INR and COVID-19 severity and mortality: a systematic review with meta-analysis and meta-regression","volume":"66","author":"Zinellu","year":"2021","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.jtha.2024.02.013_bib14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/biomedicines11030939","article-title":"Natural course of COVID-19 and independent predictors of mortality","volume":"11","author":"Orlando","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtha.2024.02.013_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/labmed\/lmaa067","article-title":"Thrombocytopenia is associated with COVID-19 severity and outcome: an updated meta-analysis of 5637 patients with multiple outcomes","volume":"52","author":"Zong","year":"2021","journal-title":"Lab Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.02.013_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jtha.2024.02.013_bib18","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1111\/jth.15107","article-title":"COVID-19 patients exhibit reduced procoagulant platelet responses","volume":"18","author":"Denorme","year":"2020","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.jtha.2024.02.013_bib19","first-page":"4134","article-title":"Prognostic value of fibrinogen among COVID-19 patients admitted to an emergency department: an Italian cohort study","volume":"9","author":"Di Micco","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1080\/09537104.2020.1760230","article-title":"Prediction of severe illness due to COVID-19 based on an analysis of initial fibrinogen to albumin ratio and platelet count","volume":"31","author":"Bi","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.02.013_bib21","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(20)31209-5","article-title":"COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?","volume":"395","author":"Maier","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.02.013_bib22","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/s41467-023-37269-3","article-title":"Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19","volume":"14","author":"Druzak","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2024.02.013_bib23","first-page":"1740","article-title":"Viscoelastometric testing to assess hemostasis of COVID-19: a systematic review","volume":"10","author":"Bareille","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib24","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s11239-021-02438-y","article-title":"COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography","volume":"52","author":"Maier","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.02.013_bib25","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2174\/1389450123666220826162900","article-title":"Fibrinogen, fibrin, and fibrin degradation products in COVID-19","volume":"23","author":"Kangro","year":"2022","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jtha.2024.02.013_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtha.2024.02.013_bib27","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.7861\/clinmed.2020-0346","article-title":"Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?","volume":"20","author":"Ladikou","year":"2020","journal-title":"Clin Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib28","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2024.02.013_bib29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib30","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.2022.13072","article-title":"Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients","volume":"328","author":"Lo Re","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.02.013_bib31","doi-asserted-by":"crossref","DOI":"10.2196\/35860","article-title":"Characterizing thrombotic complication risk factors associated with COVID-19 via heterogeneous patient data: retrospective observational study","volume":"24","author":"Rosario","year":"2022","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.jtha.2024.02.013_bib32","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1053\/j.jvca.2022.03.032","article-title":"Thrombosis and coagulopathy in COVID-19 patients receiving ECMO: a narrative review of current literature","volume":"36","author":"Yusuff","year":"2022","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2024.02.013_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/1570161119666211014162409","article-title":"COVID-19-associated coagulopathy and thromboembolism: determination of their patterns and risk factors as predictors of mortality among severe COVID-19 patients","volume":"20","author":"Naqvi","year":"2022","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jtha.2024.02.013_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.14191","article-title":"Interim Guidance; Coagulation Products Safety, Supply and Access (CPSSA) Committee of the World Federation of Hemophilia. Management of COVID-19-associated coagulopathy in persons with haemophilia","volume":"27","author":"Pipe","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.02.013_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib37","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated d-dimer concentration (ACTION): an open-label, multicentre, randomized, controlled trial","volume":"12","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.02.013_bib38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"Iba","year":"2020","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jtha.2024.02.013_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib40","article-title":"Comparison of COVID-19 induced respiratory failure and typical ARDS: similarities and differences","volume":"9","author":"Lu","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12575-021-00142-y","article-title":"Anatomical and pathological observation and analysis of SARS and COVID-19: microthrombosis is the main cause of death","volume":"23","author":"Chen","year":"2021","journal-title":"Biol Proced Online"},{"key":"10.1016\/j.jtha.2024.02.013_bib43","doi-asserted-by":"crossref","first-page":"E1065","DOI":"10.1503\/cmaj.201553","article-title":"Kidney injury associated with COVID-19","volume":"192","author":"Blum","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.jtha.2024.02.013_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.784505","article-title":"Circulating microparticles in the pathogenesis and early anticoagulation of thrombosis in COVID-19 with kidney injury","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jtha.2024.02.013_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/j.ajkd.2022.10.014","article-title":"Renal thrombotic microangiopathy: a review","volume":"81","author":"Genest","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jtha.2024.02.013_bib46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ndt\/gfaa184","article-title":"Acute kidney injury in patients with COVID-19: an update on the pathophysiology","volume":"36","author":"Izzedine","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jtha.2024.02.013_bib47","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1681\/ASN.2020050699","article-title":"COVID-19-associated kidney injury: a case series of kidney biopsy findings","volume":"31","author":"Sharma","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jtha.2024.02.013_bib48","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtha.2024.02.013_bib49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10456-023-09878-5","article-title":"Damage to endothelial barriers and its contribution to long COVID","volume":"27","author":"Wu","year":"2024","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jtha.2024.02.013_bib50","article-title":"What role does microthrombosis play in long COVID?","author":"Iba","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12809","article-title":"Dutch COVID & Thrombosis Coalition (DCTC). Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units: a retrospective cohort study","volume":"6","author":"Noordermeer","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0041-1729856","article-title":"Is lupus anticoagulant a significant feature of COVID-19? A critical appraisal of the literature","volume":"48","author":"Favaloro","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2024.02.013_bib54","doi-asserted-by":"crossref","first-page":"25018","DOI":"10.1073\/pnas.2010540117","article-title":"Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients","volume":"117","author":"Holter","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.02.013_bib55","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jacc.2022.04.060","article-title":"Association of blood viscosity with mortality among patients hospitalized with COVID-19","volume":"80","author":"Choi","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2024.02.013_bib56","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamainternmed.2022.3858","article-title":"Clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19","volume":"182","author":"Xie","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtha.2024.02.013_bib57","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.3390\/ijms24108945","article-title":"Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidence","volume":"24","author":"Ragnoli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.02.013_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100742","article-title":"Thrombosis and coagulopathy in COVID-19","volume":"46","author":"G\u00f3mez-Mesa","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jtha.2024.02.013_bib59","doi-asserted-by":"crossref","first-page":"E95","DOI":"10.1093\/eurheartj\/suab100","article-title":"Coagulopathy and COVID-19","volume":"23","author":"Lorini","year":"2021","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.jtha.2024.02.013_bib60","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/hematology.2021000297","article-title":"How to recognize and manage COVID-19-associated coagulopathy","volume":"2021","author":"Gerber","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2024.02.013_bib61","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib62","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19","volume":"20","author":"Schulman","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib63","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.jtha.2024.02.011","article-title":"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19","volume":"22","author":"Schulman","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.02.013_bib64","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/jth.15462","article-title":"Physician experiences in management of COVID-19-associated coagulopathy in pregnancy: communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis","volume":"19","author":"Jevtic","year":"2021","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T05:06:50Z","timestamp":1748754410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1538783624001156"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.02.013","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}